

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein maturation by protein folding (GO:0022417) | 8.47953739 |
| 2 | establishment of viral latency (GO:0019043) | 7.29548630 |
| 3 | establishment of integrated proviral latency (GO:0075713) | 7.29327176 |
| 4 | extracellular fibril organization (GO:0043206) | 6.68660702 |
| 5 | fibril organization (GO:0097435) | 5.60901677 |
| 6 | endothelial tube morphogenesis (GO:0061154) | 5.46429021 |
| 7 | morphogenesis of an endothelium (GO:0003159) | 5.46429021 |
| 8 | mitotic nuclear envelope reassembly (GO:0007084) | 5.26155717 |
| 9 | nuclear envelope reassembly (GO:0031468) | 5.26155717 |
| 10 | positive regulation of actin filament depolymerization (GO:0030836) | 5.22841972 |
| 11 | response to gravity (GO:0009629) | 4.99995156 |
| 12 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 4.93094479 |
| 13 | muscle cell migration (GO:0014812) | 4.82870129 |
| 14 | regulation of metalloenzyme activity (GO:0048552) | 4.82042329 |
| 15 | * detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 4.64993221 |
| 16 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 4.33415180 |
| 17 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 4.33415180 |
| 18 | sequestering of actin monomers (GO:0042989) | 4.23508833 |
| 19 | negative regulation of glycoprotein metabolic process (GO:1903019) | 4.21353481 |
| 20 | DNA unwinding involved in DNA replication (GO:0006268) | 4.16737608 |
| 21 | barbed-end actin filament capping (GO:0051016) | 4.07924073 |
| 22 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.06334891 |
| 23 | proteasome assembly (GO:0043248) | 4.04963725 |
| 24 | type B pancreatic cell proliferation (GO:0044342) | 4.04163731 |
| 25 | Golgi transport vesicle coating (GO:0048200) | 4.03866099 |
| 26 | COPI coating of Golgi vesicle (GO:0048205) | 4.03866099 |
| 27 | actin filament depolymerization (GO:0030042) | 3.96804655 |
| 28 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.88286040 |
| 29 | pattern specification involved in kidney development (GO:0061004) | 3.87502027 |
| 30 | protein retention in ER lumen (GO:0006621) | 3.78820567 |
| 31 | * detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 3.74151759 |
| 32 | membrane raft organization (GO:0031579) | 3.73840784 |
| 33 | positive regulation of pseudopodium assembly (GO:0031274) | 3.72537607 |
| 34 | galactose catabolic process (GO:0019388) | 3.72427630 |
| 35 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.72221150 |
| 36 | glomerular visceral epithelial cell development (GO:0072015) | 3.62016699 |
| 37 | response to interferon-beta (GO:0035456) | 3.55702184 |
| 38 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.52564898 |
| 39 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.52192160 |
| 40 | galactose metabolic process (GO:0006012) | 3.51048318 |
| 41 | nucleoside transmembrane transport (GO:1901642) | 3.45408748 |
| 42 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.39537925 |
| 43 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.38290120 |
| 44 | regulation of pseudopodium assembly (GO:0031272) | 3.38125219 |
| 45 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.35901762 |
| 46 | myoblast migration (GO:0051451) | 3.34272492 |
| 47 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.28465905 |
| 48 | cellular copper ion homeostasis (GO:0006878) | 3.23756818 |
| 49 | fibrinolysis (GO:0042730) | 3.22651759 |
| 50 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.18197527 |
| 51 | glomerular epithelial cell development (GO:0072310) | 3.13256903 |
| 52 | negative regulation of metanephros development (GO:0072217) | 3.11949392 |
| 53 | positive regulation of protein complex disassembly (GO:0043243) | 3.07908713 |
| 54 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.06587179 |
| 55 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.03390037 |
| 56 | mesonephros development (GO:0001823) | 3.02360883 |
| 57 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.02331263 |
| 58 | negative regulation of ligase activity (GO:0051352) | 3.02331263 |
| 59 | endosome to pigment granule transport (GO:0043485) | 3.00466321 |
| 60 | endosome to melanosome transport (GO:0035646) | 3.00466321 |
| 61 | heterochromatin organization (GO:0070828) | 3.00423244 |
| 62 | regulation of extracellular matrix disassembly (GO:0010715) | 2.99008952 |
| 63 | negative regulation of mitochondrion organization (GO:0010823) | 2.98014909 |
| 64 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.97200622 |
| 65 | cortical actin cytoskeleton organization (GO:0030866) | 2.94008248 |
| 66 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.93007481 |
| 67 | cellular response to zinc ion (GO:0071294) | 2.91443653 |
| 68 | AMP metabolic process (GO:0046033) | 2.91174727 |
| 69 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.91017351 |
| 70 | regulation of mitochondrial translation (GO:0070129) | 2.91001433 |
| 71 | pyrimidine nucleoside salvage (GO:0043097) | 2.90101562 |
| 72 | pyrimidine-containing compound salvage (GO:0008655) | 2.90101562 |
| 73 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.89696523 |
| 74 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.88628391 |
| 75 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.88195474 |
| 76 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.88195474 |
| 77 | lipopolysaccharide metabolic process (GO:0008653) | 2.87574061 |
| 78 | glycolytic process (GO:0006096) | 2.87551298 |
| 79 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.87423381 |
| 80 | inner ear receptor cell differentiation (GO:0060113) | 2.85761228 |
| 81 | cell proliferation involved in kidney development (GO:0072111) | 2.83608794 |
| 82 | negative regulation of kidney development (GO:0090185) | 2.82836623 |
| 83 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.81209347 |
| 84 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.81209347 |
| 85 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.81209347 |
| 86 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.80023258 |
| 87 | GDP-mannose metabolic process (GO:0019673) | 2.74201025 |
| 88 | lung morphogenesis (GO:0060425) | 2.73243581 |
| 89 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.72904108 |
| 90 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.72904108 |
| 91 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.71330271 |
| 92 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.70138621 |
| 93 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.70075064 |
| 94 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.69443097 |
| 95 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.66440858 |
| 96 | nucleotide transmembrane transport (GO:1901679) | 2.66128361 |
| 97 | positive regulation of TOR signaling (GO:0032008) | 2.64405088 |
| 98 | mesenchymal cell proliferation (GO:0010463) | 2.64369785 |
| 99 | respiratory tube development (GO:0030323) | 2.63255683 |
| 100 | retina homeostasis (GO:0001895) | 2.62279085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.04862010 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.88568018 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.51076031 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.19983538 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.03375972 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.72852324 |
| 7 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.70162844 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.69211213 |
| 9 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.60233643 |
| 10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.59084198 |
| 11 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.57982902 |
| 12 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.50794702 |
| 13 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.44189210 |
| 14 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.34793852 |
| 15 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.27473690 |
| 16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.24488163 |
| 17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.18986412 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.12417553 |
| 19 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.10816293 |
| 20 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.10039402 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.01293907 |
| 22 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.00680647 |
| 23 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.99132419 |
| 24 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.97307970 |
| 25 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.92130129 |
| 26 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.85866559 |
| 27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.85331054 |
| 28 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.83307304 |
| 29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.80984987 |
| 30 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.80801299 |
| 31 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.79673535 |
| 32 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.79027132 |
| 33 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.73765256 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.69348504 |
| 35 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.67038911 |
| 36 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.66585425 |
| 37 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.66276414 |
| 38 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.65694146 |
| 39 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.65122812 |
| 40 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.63814531 |
| 41 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.55765964 |
| 42 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54563323 |
| 43 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51804197 |
| 44 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.47177569 |
| 45 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46453052 |
| 46 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.46026903 |
| 47 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.45281925 |
| 48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43649668 |
| 49 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.41196952 |
| 50 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.40753306 |
| 51 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.40430852 |
| 52 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.40430852 |
| 53 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.39526999 |
| 54 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.38207795 |
| 55 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.36554139 |
| 56 | ATF3_27146783_Chip-Seq_COLON_Human | 1.35180293 |
| 57 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.34540462 |
| 58 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34303604 |
| 59 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.33178179 |
| 60 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.32499344 |
| 61 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.30910566 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.30671716 |
| 63 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.29724223 |
| 64 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.29313741 |
| 65 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.27965913 |
| 66 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.22005513 |
| 67 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.18615026 |
| 68 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18585947 |
| 69 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.18083616 |
| 70 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16393010 |
| 71 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.16146277 |
| 72 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.15711257 |
| 73 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.15448092 |
| 74 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.14859556 |
| 75 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.14296104 |
| 76 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12469525 |
| 77 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.11917349 |
| 78 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11219721 |
| 79 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.11184009 |
| 80 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.08362433 |
| 81 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.06410000 |
| 82 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.06146354 |
| 83 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.05657059 |
| 84 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04781998 |
| 85 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.04770147 |
| 86 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.04701580 |
| 87 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04484544 |
| 88 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04139287 |
| 89 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.02788390 |
| 90 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02700826 |
| 91 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02348459 |
| 92 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.02136471 |
| 93 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00076479 |
| 94 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.98875798 |
| 95 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.98261444 |
| 96 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.97961026 |
| 97 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.97611039 |
| 98 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.96989984 |
| 99 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.95413665 |
| 100 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.95359523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003123_paternal_imprinting | 4.65643787 |
| 2 | MP0005257_abnormal_intraocular_pressure | 4.42765072 |
| 3 | MP0003191_abnormal_cellular_cholesterol | 4.37703082 |
| 4 | MP0010030_abnormal_orbit_morphology | 3.79702563 |
| 5 | MP0000751_myopathy | 3.69418727 |
| 6 | MP0004510_myositis | 3.16996141 |
| 7 | MP0002877_abnormal_melanocyte_morpholog | 3.04669515 |
| 8 | MP0003315_abnormal_perineum_morphology | 3.00335451 |
| 9 | MP0005165_increased_susceptibility_to | 2.91607250 |
| 10 | MP0000750_abnormal_muscle_regeneration | 2.91513312 |
| 11 | MP0003950_abnormal_plasma_membrane | 2.86421629 |
| 12 | MP0001542_abnormal_bone_strength | 2.85710072 |
| 13 | MP0000749_muscle_degeneration | 2.67577750 |
| 14 | MP0004272_abnormal_basement_membrane | 2.66721635 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.55291404 |
| 16 | MP0003075_altered_response_to | 2.51500643 |
| 17 | MP0002332_abnormal_exercise_endurance | 2.50093588 |
| 18 | MP0003566_abnormal_cell_adhesion | 2.17950369 |
| 19 | MP0005367_renal/urinary_system_phenotyp | 2.16381377 |
| 20 | MP0000516_abnormal_urinary_system | 2.16381377 |
| 21 | MP0008775_abnormal_heart_ventricle | 2.00416954 |
| 22 | MP0005330_cardiomyopathy | 1.97288732 |
| 23 | MP0000343_altered_response_to | 1.95561093 |
| 24 | MP0009840_abnormal_foam_cell | 1.91237533 |
| 25 | MP0006054_spinal_hemorrhage | 1.85867491 |
| 26 | MP0001299_abnormal_eye_distance/ | 1.83678237 |
| 27 | MP0000858_altered_metastatic_potential | 1.77745570 |
| 28 | MP0001853_heart_inflammation | 1.70429652 |
| 29 | MP0003806_abnormal_nucleotide_metabolis | 1.62060348 |
| 30 | MP0008260_abnormal_autophagy | 1.60835026 |
| 31 | MP0003786_premature_aging | 1.58682624 |
| 32 | MP0009780_abnormal_chondrocyte_physiolo | 1.50622398 |
| 33 | MP0008438_abnormal_cutaneous_collagen | 1.47412319 |
| 34 | MP0005360_urolithiasis | 1.45472399 |
| 35 | MP0003329_amyloid_beta_deposits | 1.35036984 |
| 36 | MP0005670_abnormal_white_adipose | 1.34456610 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.32319826 |
| 38 | MP0002653_abnormal_ependyma_morphology | 1.28197379 |
| 39 | MP0002177_abnormal_outer_ear | 1.27486293 |
| 40 | MP0003436_decreased_susceptibility_to | 1.25591907 |
| 41 | MP0005197_abnormal_uvea_morphology | 1.24589496 |
| 42 | MP0003279_aneurysm | 1.24079329 |
| 43 | MP0000647_abnormal_sebaceous_gland | 1.20629658 |
| 44 | MP0003186_abnormal_redox_activity | 1.18275739 |
| 45 | MP0002972_abnormal_cardiac_muscle | 1.17440807 |
| 46 | MP0002060_abnormal_skin_morphology | 1.15767874 |
| 47 | MP0005166_decreased_susceptibility_to | 1.12028583 |
| 48 | MP0001905_abnormal_dopamine_level | 1.10966282 |
| 49 | MP0009697_abnormal_copulation | 1.09940436 |
| 50 | MP0001243_abnormal_dermal_layer | 1.08280016 |
| 51 | MP0003656_abnormal_erythrocyte_physiolo | 1.08270445 |
| 52 | MP0010368_abnormal_lymphatic_system | 1.05884079 |
| 53 | MP0004147_increased_porphyrin_level | 1.03962398 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.03071232 |
| 55 | MP0002282_abnormal_trachea_morphology | 1.01124883 |
| 56 | MP0003638_abnormal_response/metabolism_ | 0.99597970 |
| 57 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.98630324 |
| 58 | MP0008007_abnormal_cellular_replicative | 0.98381947 |
| 59 | MP0006036_abnormal_mitochondrial_physio | 0.95468110 |
| 60 | MP0000762_abnormal_tongue_morphology | 0.94317159 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 0.92980212 |
| 62 | MP0005083_abnormal_biliary_tract | 0.92351811 |
| 63 | MP0005164_abnormal_response_to | 0.91981217 |
| 64 | MP0001346_abnormal_lacrimal_gland | 0.87151825 |
| 65 | MP0002106_abnormal_muscle_physiology | 0.86581244 |
| 66 | MP0003195_calcinosis | 0.84664868 |
| 67 | MP0000747_muscle_weakness | 0.84615533 |
| 68 | MP0000534_abnormal_ureter_morphology | 0.83078571 |
| 69 | MP0000358_abnormal_cell_content/ | 0.79977169 |
| 70 | MP0001727_abnormal_embryo_implantation | 0.79097657 |
| 71 | MP0003718_maternal_effect | 0.73650386 |
| 72 | MP0000604_amyloidosis | 0.71918516 |
| 73 | MP0005451_abnormal_body_composition | 0.71829966 |
| 74 | MP0002295_abnormal_pulmonary_circulatio | 0.69835586 |
| 75 | MP0009053_abnormal_anal_canal | 0.69207831 |
| 76 | MP0002837_dystrophic_cardiac_calcinosis | 0.68892883 |
| 77 | MP0004957_abnormal_blastocyst_morpholog | 0.66344311 |
| 78 | MP0000249_abnormal_blood_vessel | 0.64859170 |
| 79 | MP0005390_skeleton_phenotype | 0.64741590 |
| 80 | MP0003077_abnormal_cell_cycle | 0.63983206 |
| 81 | MP0008932_abnormal_embryonic_tissue | 0.62347421 |
| 82 | MP0008875_abnormal_xenobiotic_pharmacok | 0.61206232 |
| 83 | MP0003942_abnormal_urinary_system | 0.60478157 |
| 84 | MP0005023_abnormal_wound_healing | 0.60086764 |
| 85 | MP0003121_genomic_imprinting | 0.59773830 |
| 86 | MP0004233_abnormal_muscle_weight | 0.59725384 |
| 87 | MP0001879_abnormal_lymphatic_vessel | 0.58333045 |
| 88 | MP0009764_decreased_sensitivity_to | 0.58016412 |
| 89 | MP0002019_abnormal_tumor_incidence | 0.57724488 |
| 90 | MP0009278_abnormal_bone_marrow | 0.57656004 |
| 91 | MP0001340_abnormal_eyelid_morphology | 0.57273264 |
| 92 | MP0002006_tumorigenesis | 0.56611874 |
| 93 | MP0005501_abnormal_skin_physiology | 0.56524919 |
| 94 | MP0005266_abnormal_metabolism | 0.56006157 |
| 95 | MP0003091_abnormal_cell_migration | 0.55965130 |
| 96 | MP0001216_abnormal_epidermal_layer | 0.53842819 |
| 97 | MP0000613_abnormal_salivary_gland | 0.53478483 |
| 98 | MP0005395_other_phenotype | 0.52175468 |
| 99 | MP0003693_abnormal_embryo_hatching | 0.52118601 |
| 100 | MP0002796_impaired_skin_barrier | 0.48680593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Amyloidosis (HP:0011034) | 6.03943551 |
| 2 | Glucose intolerance (HP:0000833) | 4.65282810 |
| 3 | Adrenal hypoplasia (HP:0000835) | 4.49065504 |
| 4 | Reduced subcutaneous adipose tissue (HP:0003758) | 4.37856136 |
| 5 | Premature rupture of membranes (HP:0001788) | 4.14426473 |
| 6 | Delayed CNS myelination (HP:0002188) | 4.09965349 |
| 7 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.73353782 |
| 8 | Osteolytic defects of the hand bones (HP:0009699) | 3.73353782 |
| 9 | Microglossia (HP:0000171) | 3.68813167 |
| 10 | Upper limb muscle weakness (HP:0003484) | 3.58419008 |
| 11 | Distal lower limb muscle weakness (HP:0009053) | 3.50495597 |
| 12 | Vascular calcification (HP:0004934) | 3.49600352 |
| 13 | Hepatocellular necrosis (HP:0001404) | 3.35755499 |
| 14 | Short nail (HP:0001799) | 3.16089696 |
| 15 | Abnormal glucose tolerance (HP:0001952) | 3.15932689 |
| 16 | Axonal loss (HP:0003447) | 3.11642983 |
| 17 | Insulin resistance (HP:0000855) | 3.09092355 |
| 18 | Cardiovascular calcification (HP:0011915) | 3.06393443 |
| 19 | Hepatic necrosis (HP:0002605) | 3.04340665 |
| 20 | Increased serum pyruvate (HP:0003542) | 3.03821808 |
| 21 | Entropion (HP:0000621) | 3.02635333 |
| 22 | Cholecystitis (HP:0001082) | 3.00125051 |
| 23 | Abnormal gallbladder physiology (HP:0012438) | 3.00125051 |
| 24 | Mitochondrial inheritance (HP:0001427) | 2.97887660 |
| 25 | Vertebral compression fractures (HP:0002953) | 2.96567817 |
| 26 | Limb-girdle muscle atrophy (HP:0003797) | 2.94655898 |
| 27 | Joint hemorrhage (HP:0005261) | 2.89592405 |
| 28 | Abnormality of glycolysis (HP:0004366) | 2.84750276 |
| 29 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.79035727 |
| 30 | Rough bone trabeculation (HP:0100670) | 2.78447941 |
| 31 | Shoulder girdle muscle weakness (HP:0003547) | 2.76965912 |
| 32 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.74273761 |
| 33 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.74210229 |
| 34 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.74210229 |
| 35 | Type I transferrin isoform profile (HP:0003642) | 2.72262358 |
| 36 | Pelvic girdle muscle weakness (HP:0003749) | 2.72022085 |
| 37 | Acute necrotizing encephalopathy (HP:0006965) | 2.71114038 |
| 38 | Reduced antithrombin III activity (HP:0001976) | 2.70733958 |
| 39 | Distal lower limb amyotrophy (HP:0008944) | 2.69562394 |
| 40 | Hand muscle atrophy (HP:0009130) | 2.62626870 |
| 41 | Abnormality of the sella turcica (HP:0002679) | 2.56827744 |
| 42 | Myocardial infarction (HP:0001658) | 2.55337221 |
| 43 | Bifid uvula (HP:0000193) | 2.54527743 |
| 44 | Flat capital femoral epiphysis (HP:0003370) | 2.53235349 |
| 45 | Prolonged neonatal jaundice (HP:0006579) | 2.46460735 |
| 46 | Late onset (HP:0003584) | 2.44024535 |
| 47 | J-shaped sella turcica (HP:0002680) | 2.42377442 |
| 48 | Increased connective tissue (HP:0009025) | 2.38164793 |
| 49 | Hepatosplenomegaly (HP:0001433) | 2.38075178 |
| 50 | Exercise intolerance (HP:0003546) | 2.36515390 |
| 51 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.35699094 |
| 52 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.35699094 |
| 53 | Abnormality of glycolipid metabolism (HP:0010969) | 2.35699094 |
| 54 | Difficulty climbing stairs (HP:0003551) | 2.35479653 |
| 55 | Increased CSF lactate (HP:0002490) | 2.34189055 |
| 56 | Sparse eyelashes (HP:0000653) | 2.33062096 |
| 57 | Severe muscular hypotonia (HP:0006829) | 2.31940499 |
| 58 | Vacuolated lymphocytes (HP:0001922) | 2.31712759 |
| 59 | Congenital, generalized hypertrichosis (HP:0004540) | 2.31688948 |
| 60 | Secondary amenorrhea (HP:0000869) | 2.30899123 |
| 61 | Atrophic scars (HP:0001075) | 2.29453296 |
| 62 | Abnormal protein glycosylation (HP:0012346) | 2.28898049 |
| 63 | Abnormal glycosylation (HP:0012345) | 2.28898049 |
| 64 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.28898049 |
| 65 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.28898049 |
| 66 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.26607966 |
| 67 | Short clavicles (HP:0000894) | 2.21804334 |
| 68 | Renal Fanconi syndrome (HP:0001994) | 2.20562528 |
| 69 | Palpitations (HP:0001962) | 2.18714077 |
| 70 | Fatigue (HP:0012378) | 2.18281612 |
| 71 | Down-sloping shoulders (HP:0200021) | 2.17773553 |
| 72 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.16061554 |
| 73 | Acute encephalopathy (HP:0006846) | 2.15966431 |
| 74 | Exertional dyspnea (HP:0002875) | 2.13952442 |
| 75 | Upper limb amyotrophy (HP:0009129) | 2.12839439 |
| 76 | Distal upper limb amyotrophy (HP:0007149) | 2.12839439 |
| 77 | Progressive macrocephaly (HP:0004481) | 2.12626078 |
| 78 | Bradycardia (HP:0001662) | 2.12267202 |
| 79 | Opisthotonus (HP:0002179) | 2.11980471 |
| 80 | Hypoalphalipoproteinemia (HP:0003233) | 2.09905763 |
| 81 | Dysostosis multiplex (HP:0000943) | 2.08570975 |
| 82 | Polygenic inheritance (HP:0010982) | 2.08531978 |
| 83 | Acanthosis nigricans (HP:0000956) | 2.08276611 |
| 84 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.07217115 |
| 85 | Increased hepatocellular lipid droplets (HP:0006565) | 2.07015053 |
| 86 | Emotional lability (HP:0000712) | 2.06535097 |
| 87 | Increased intramyocellular lipid droplets (HP:0012240) | 2.03516812 |
| 88 | Impaired platelet aggregation (HP:0003540) | 2.03275868 |
| 89 | Abnormal platelet function (HP:0011869) | 2.03275868 |
| 90 | Abnormal spermatogenesis (HP:0008669) | 2.01467480 |
| 91 | Proximal placement of thumb (HP:0009623) | 2.00515038 |
| 92 | Joint stiffness (HP:0001387) | 1.98798059 |
| 93 | Neck muscle weakness (HP:0000467) | 1.96498983 |
| 94 | Testicular atrophy (HP:0000029) | 1.95407444 |
| 95 | Right ventricular cardiomyopathy (HP:0011663) | 1.94441025 |
| 96 | Natal tooth (HP:0000695) | 1.92199473 |
| 97 | Abnormal trabecular bone morphology (HP:0100671) | 1.91333335 |
| 98 | Progressive neurologic deterioration (HP:0002344) | 1.90209633 |
| 99 | Hypergonadotropic hypogonadism (HP:0000815) | 1.89868860 |
| 100 | Myoglobinuria (HP:0002913) | 1.88126428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK1 | 5.52327815 |
| 2 | VRK2 | 5.49210131 |
| 3 | TESK2 | 5.29060256 |
| 4 | NME2 | 4.65117348 |
| 5 | LIMK1 | 4.38508656 |
| 6 | EPHA2 | 3.96489777 |
| 7 | LMTK2 | 3.05503931 |
| 8 | ARAF | 2.82240783 |
| 9 | PIM2 | 2.41388531 |
| 10 | BUB1 | 2.32348589 |
| 11 | BCKDK | 2.11335602 |
| 12 | MAP2K7 | 1.99444565 |
| 13 | DAPK1 | 1.93678227 |
| 14 | ERN1 | 1.90309588 |
| 15 | STK10 | 1.57056186 |
| 16 | PHKG1 | 1.55693620 |
| 17 | PHKG2 | 1.55693620 |
| 18 | TAOK2 | 1.55152012 |
| 19 | MOS | 1.45259165 |
| 20 | IRAK3 | 1.41734834 |
| 21 | VRK1 | 1.34005546 |
| 22 | PAK4 | 1.33765523 |
| 23 | KDR | 1.33265262 |
| 24 | ABL2 | 1.29193266 |
| 25 | MAPKAPK3 | 1.23817939 |
| 26 | MAP3K12 | 1.22145972 |
| 27 | CSNK1G3 | 1.17350462 |
| 28 | MST1R | 1.15088509 |
| 29 | SRPK1 | 1.11886107 |
| 30 | TAF1 | 1.10123182 |
| 31 | CSNK1A1L | 1.06321898 |
| 32 | HIPK2 | 1.05334681 |
| 33 | ERBB4 | 1.03403107 |
| 34 | MST4 | 1.03124630 |
| 35 | STK16 | 0.96470308 |
| 36 | NEK1 | 0.96422508 |
| 37 | PTK2B | 0.92401327 |
| 38 | MAP3K11 | 0.91730215 |
| 39 | GRK5 | 0.90444893 |
| 40 | EPHB2 | 0.87410870 |
| 41 | PTK2 | 0.85393011 |
| 42 | CSNK1G2 | 0.84243777 |
| 43 | CCNB1 | 0.82713476 |
| 44 | CSNK1G1 | 0.82337044 |
| 45 | BRSK1 | 0.79854071 |
| 46 | AURKA | 0.77889968 |
| 47 | SCYL2 | 0.77797871 |
| 48 | TGFBR2 | 0.76801145 |
| 49 | BRAF | 0.71766348 |
| 50 | MYLK | 0.70790630 |
| 51 | PRPF4B | 0.69086295 |
| 52 | PAK1 | 0.68578735 |
| 53 | TBK1 | 0.68518173 |
| 54 | ILK | 0.67848254 |
| 55 | DAPK3 | 0.66078499 |
| 56 | DAPK2 | 0.64323873 |
| 57 | LRRK2 | 0.63426583 |
| 58 | GRK7 | 0.63057479 |
| 59 | MAP3K3 | 0.61671459 |
| 60 | NUAK1 | 0.61233641 |
| 61 | BMX | 0.57391076 |
| 62 | EPHB1 | 0.57126260 |
| 63 | CDK8 | 0.53779053 |
| 64 | CDK14 | 0.49354077 |
| 65 | SMG1 | 0.48813254 |
| 66 | PDK2 | 0.48453493 |
| 67 | CDK7 | 0.44185038 |
| 68 | PRKCI | 0.42029942 |
| 69 | CDK15 | 0.41786420 |
| 70 | CDK18 | 0.41654761 |
| 71 | CDK19 | 0.41597897 |
| 72 | CDK11A | 0.40231859 |
| 73 | RAF1 | 0.39631659 |
| 74 | MAPKAPK2 | 0.35677164 |
| 75 | EIF2AK2 | 0.35268547 |
| 76 | ADRBK1 | 0.33832833 |
| 77 | MET | 0.33822292 |
| 78 | EPHA4 | 0.33061673 |
| 79 | GSK3A | 0.33052730 |
| 80 | PLK1 | 0.32545169 |
| 81 | AURKB | 0.32475963 |
| 82 | PLK3 | 0.32196307 |
| 83 | FER | 0.31330501 |
| 84 | CAMKK2 | 0.25807142 |
| 85 | MAPKAPK5 | 0.24470726 |
| 86 | CSNK2A2 | 0.24274356 |
| 87 | ICK | 0.21356778 |
| 88 | CDC7 | 0.20924573 |
| 89 | PTK6 | 0.20371891 |
| 90 | RPS6KA5 | 0.19952607 |
| 91 | MAP3K8 | 0.19661321 |
| 92 | CAMK2G | 0.17489806 |
| 93 | IKBKE | 0.16880117 |
| 94 | PRKD1 | 0.15778833 |
| 95 | PRKACB | 0.15667133 |
| 96 | ROCK2 | 0.15621032 |
| 97 | PBK | 0.13513051 |
| 98 | MAP3K6 | 0.11959908 |
| 99 | ROCK1 | 0.11655938 |
| 100 | CSNK1A1 | 0.09609648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.78112113 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.20141616 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.13240979 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.74754798 |
| 5 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.62857426 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.62029797 |
| 7 | Sulfur relay system_Homo sapiens_hsa04122 | 2.53344535 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.34483813 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.33246695 |
| 10 | Huntingtons disease_Homo sapiens_hsa05016 | 2.30473495 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 2.20984219 |
| 12 | Alzheimers disease_Homo sapiens_hsa05010 | 2.18654458 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.15871271 |
| 14 | Galactose metabolism_Homo sapiens_hsa00052 | 2.14786382 |
| 15 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.06806551 |
| 16 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.05641001 |
| 17 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.05359231 |
| 18 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.97291418 |
| 19 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.91091429 |
| 20 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.85537795 |
| 21 | Ribosome_Homo sapiens_hsa03010 | 1.83917367 |
| 22 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.83069078 |
| 23 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.81723029 |
| 24 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.76938461 |
| 25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.76852034 |
| 26 | * Salivary secretion_Homo sapiens_hsa04970 | 1.64123218 |
| 27 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.60408075 |
| 28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.57043579 |
| 29 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.55862254 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.51845218 |
| 31 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.50137725 |
| 32 | Carbon metabolism_Homo sapiens_hsa01200 | 1.47057716 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.42056032 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.38658250 |
| 35 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.34914026 |
| 36 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.27215583 |
| 37 | Homologous recombination_Homo sapiens_hsa03440 | 1.24875707 |
| 38 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.21201157 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.16488375 |
| 40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.16062196 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.15336734 |
| 42 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.10342379 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 1.06832801 |
| 44 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.02308991 |
| 45 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.01066715 |
| 46 | Purine metabolism_Homo sapiens_hsa00230 | 0.99638333 |
| 47 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.93347263 |
| 48 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.85108681 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.85097424 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 0.84673173 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 0.81506565 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79595092 |
| 53 | Metabolic pathways_Homo sapiens_hsa01100 | 0.76533443 |
| 54 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.76204359 |
| 55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.75119745 |
| 56 | Endocytosis_Homo sapiens_hsa04144 | 0.64748194 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61952053 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61665192 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59951661 |
| 60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.54947893 |
| 61 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.53601977 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51100543 |
| 63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.50140507 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 0.49407511 |
| 65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.49161776 |
| 66 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.49004345 |
| 67 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48813793 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.48113878 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.47678818 |
| 70 | Salmonella infection_Homo sapiens_hsa05132 | 0.47413096 |
| 71 | Viral myocarditis_Homo sapiens_hsa05416 | 0.44322239 |
| 72 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43145352 |
| 73 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41823910 |
| 74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41680183 |
| 75 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40970123 |
| 76 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40125870 |
| 77 | Spliceosome_Homo sapiens_hsa03040 | 0.38577019 |
| 78 | Cell cycle_Homo sapiens_hsa04110 | 0.35425184 |
| 79 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.34488167 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.34077746 |
| 81 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.33373810 |
| 82 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.32886092 |
| 83 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.32659811 |
| 84 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.32583819 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | 0.31652115 |
| 86 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30389308 |
| 87 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.25196345 |
| 88 | Protein export_Homo sapiens_hsa03060 | 0.25058597 |
| 89 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.24595130 |
| 90 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.24581278 |
| 91 | Phagosome_Homo sapiens_hsa04145 | 0.23371498 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22995301 |
| 93 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.21953384 |
| 94 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.21496580 |
| 95 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.20002612 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19476235 |
| 97 | RNA transport_Homo sapiens_hsa03013 | 0.19246359 |
| 98 | Legionellosis_Homo sapiens_hsa05134 | 0.17118811 |
| 99 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.16717981 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.15986149 |

